Morbidity and Mortality Weekly Report, December 16, 1988 / 37(49);755-758,764
Since 1984, in many areas of the United States, reported rates of syphilis have greatly increased (1). Between 1984 and 1987, annual rates of syphilis (primary and secondary) increased 70% in the state of Connecticut and 74% in the city of Philadelphia (Figure 1). These trends have continued in 1988; in the first quarter of this year, annualized rates increased by 70% in Connecticut and by 25% in Philadelphia compared with 1987 annual rates.
Morbidity and Mortality Weekly Report, December 09, 1988 / 37(48);736-740,745-747
Screening tests for antibody to human T-lymphotropic virus type I (HTLV-I), the first-recognized human retrovirus, have been licensed by the Food and Drug Administration (FDA). These tests have been recommended by the FDA for screening of blood and cellular components donated for transfusion.
Morbidity and Mortality Weekly Report, December 02, 1988 / 37(47);717-721
In 1987, CDC began to assist state and local departments of education in assessing human immunodeficiency virus (HIV)-related beliefs, knowledge, and behaviors among high school students in states and cities with the highest cumulative incidence of acquired immunodeficiency syndrome (AIDS).
Morbidity and Mortality Weekly Report, November 10, 1988 / 37(44);677-679
From October 1985 through March 1988, 1,525,869 recruit applicants were tested; presence of HIV-1 antibody was confirmed by enzyme immunoassay and Western blot in 2152 (1.4 per 1000). During this period, seroprevalence rates based on 6-month intervals decreased from 1.5 to 1.2 per 1000 applicants.
Morbidity and Mortality Weekly Report, October 07, 1988 / 37(39);600-602,607-608
The clinical manifestations, serologic responses, efficacy of treatment, and occurrence of complications of syphilis may be altered in patients coinfected with human immunodeficiency virus (HIV). Because syphilis is a disease with a broad range of manifestations and variable course, assessing reports of unusual clinical or lab- oratory findings in HIV-coinfected patients is difficult.
Morbidity and Mortality Weekly Report, September 29, 1988 / 37(38);593-6
Most pneumonia-attributable deaths occur among the elderly. In New York City (NYC), however, the number and rate of such deaths among younger persons have increased in association with human immunodeficiency virus (HIV) infections in intravenous-drug abusers (IVDAs) (1,2). In addition, data from CDC's 121 Cities Mortality Surveillance System (CMSS) suggest that similar trends may be occurring in other cities.
Morbidity and Mortality Weekly Report, September 23, 1988 / 37(37);565-8
Human immunodeficiency virus type 1 (HIV-1) and other sexually transmitted diseases (STDs) are spread from infected persons to their sex partners during unprotected sexual exposures. The Public Health Service estimates that between 945,000 and 1,410,000 Americans have been infected with HIV-1, but the number of Americans at risk because of unprotected sexual exposures is unknown. Estimates of current levels of sexual activity are based in part on a survey of sexual behavior conducted 40 years ago.
Morbidity and Mortality Weekly Report, September 23, 1988 / 37(37);571-572,577
In March 1987, a 48-year-old homosexual man with oral thrush and a single dermatome zoster infection was found to be human immunodeficiency virus (HIV)- seropositive by enzyme immunoassay and Western blot. He had a depressed T4 lymphocyte count of 359 cells/mm3 (normal: greater than or equal to800 T4 cells/mm3), and weekly pentamidine aerosol treatments were begun for prophylaxis against Pneumocystis carinii pneumonia (PCP).
Morbidity and Mortality Weekly Report, September 16, 1988 / 37(36);551-554,559
This article summarizes the third report to the Domestic Policy Council (DPC) on the prevalence and rate of spread of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) in the United States. The first report (1) extensively reviewed data on the prevalence and incidence of HIV infection. The second report was summarized in April 1988 (2). The third report was delivered to the DPC on July 22, 1988; its major points are summarized below, with information updated where appropriate.
Morbidity and Mortality Weekly Report, September 02, 1988 / 37(34);517-519
The prevalence of human immunodeficiency virus (HIV) was determined for patients attending a health clinic serving approximately 4500 migrant and seasonal farmworkers in North Carolina. From August 27 to October 27, 1987, all blood specimens routinely collected at the clinic for other purposes were tested for HIV antibody by enzyme immunoassay, with confirmation by Western blot; the specimens had no personal identifiers.
Morbidity and Mortality Weekly Report, August 05, 1988 / 37(30);461-463
In January 1986, the U.S. Department of Defense began screening all active-duty military personnel for antibody to the human immunodeficiency virus type 1 (HIV-1). A total of 1,752,191 persons who remained on active duty as of April 24, 1988, were screened. HIV-1 antibody was confirmed by Western blot in 2,232 (1.3 per 1,000) of thesee persons.
Morbidity and Mortality Weekly Report, July 01, 1988 / 37(25);393-6,401-2
Partner notification, a component of sexually transmitted disease (STD) control programs for many years (1), is a means to identify and target risk-reduction education to individuals at high risk for contracting or transmitting HIV infection. When applied to HIV infection, the term "partner" includes not only sex partners but also intravenous drug users who share needles.
Morbidity and Mortality Weekly Report, June 24, 1988 / 37(24);377-388
In 1983, CDC published a document entitled "Guideline for Isolation Precautions in Hospitals" that contained a section entitled "Blood and Body Fluid Precautions." The recommendations in this section called for blood and body fluid precautions when a patient was known or suspected to be infected with bloodborne pathogens. In August 1987, CDC published a document entitled "Recommendations for Prevention of HIV Transmission in Health-Care Settings".
Morbidity and Mortality Weekly Report, June 17, 1988 / 37(23);374-5
August 15-17, 1988, CDC will cosponsor a national conference on the Prevention of HIV Infection and AIDS Among Racial and Ethnic Minorities in the United States, at the Omni Shoreham Hotel, in Washington, D.C. The conference is sponsored in conjunction with the Office of Minority Health; the Alcohol, Drug Abuse, and Mental Health Administration; the Health Resources and Services Administration; and the Indian Health Service.
Morbidity and Mortality Weekly Report, May 13, 1988 / 37(18);286-288,293-5
As of March 21, 1988, 136 countries or territories throughout the world had reported a total of 84,256 cases of acquired immunodeficiency syndrome (AIDS) to the Global Programme on AIDS (GPA) (formerly the Special Programme on AIDS) of the World Health Organization (WHO) (Table 1).* Thirty-seven countries or territories had reported no AIDS cases. Reports are based on either the CDC/WHO surveillance definition, the WHO clinical definition, or a physician's diagnosis.
Morbidity and Mortality Weekly Report, May 06, 1988 / 37(17);261-9
Approximately 107 million English-language versions of a brochure, Understanding AIDS, will be distributed to every home and residential post office box by the U.S. Postal Service between May 26 and June 30, 1988. A Spanish-language version will be distributed in Puerto Rico and will also be available upon request after May 26, 1988. This national mailing marks the first time the federal government has attempted to contact virtually every resident, directly by mail, regarding a major public health problem.
Morbidity and Mortality Weekly Report, April 15, 1988 / 37(14);223-6
On December 18, 1987, CDC published the first in a series of articles about the prevalence and rate of spread of human immunodeficiency virus (HIV) infection in the United States. The article summarized a report presented to the Domestic Policy Council on November 30, 1987.
Morbidity and Mortality Weekly Report, April 01, 1988 / 37(12);183-6
The Centers for Disease Control has received reports of six cases of measles that occurred among children infected with human immunodeficiency virus (HIV) in the United States during the period 1986-1987 (Table 1). Two of these children died from measles. Like many other infections, measles appears to be more severe in persons with HIV infection.
Morbidity and Mortality Weekly Report, April 01, 1988 / 37(12);181-3
The Immunization Practices Advisory Committee (ACIP) recently reviewed data both on the risks and benefits of immunizing children infected with human immunodeficiency virus (HIV) and on severe and fatal measles in HIV-infected children in the United States. Since this review, the committee has revised its previous recommendations for measles vaccination and for mumps and rubella vaccination.
Morbidity and Mortality Weekly Report, March 11, 1988 / 37(9);133-7
Prevention is the most effective strategy for controlling the spread of infectious diseases. Prevention through avoiding exposure is the best strategy for controlling the spread of sexually transmitted disease (STD). Behavior that eliminates or reduces the risk of one STD will likely reduce the risk of all STDs. Prevention of one case of STD can result in the prevention of many subsequent cases. Abstinence and sexual intercourse with one mutually faithful uninfected partner are the only totally effective prevention strategies.
Morbidity and Mortality Weekly Report, February 05, 1988 / 37(4);57-8,63
The following recommendations regarding storage and use of semen were prepared by the Food and Drug Administration and the Centers for Disease Control with the endorsement of the American Association of Tissue Banks, the American Fertility Society, and the American College of Obstetricians and Gynecologists.
Morbidity and Mortality Weekly Report, January 29, 1988 / 37(3);33-5
The first reported case of AIDS caused by human immunodeficiency virus type 2 (HIV-2) in the United States was diagnosed in December 1987. The patient, a West African, came to the United States in 1987. In December, the patient visited a physician because of a 3-year history of weight loss and recent onset of neurologic symptoms. A CAT scan of the head revealed mass lesions that biopsy showed to be caused by Toxoplasma gondii. Biopsy of a lymph node revealed acid-fast bacteria.
Morbidity and Mortality Weekly Report, January 08, 1984 / Vol 36, No 52;833
Summary: the virus that causes acquired immunodeficiency syndrome (AIDS), were first licensed by the Food and Drug Administration (FDA) in 1985, primarily as screening tests for blood and plasma donation.
This information is designed to support, not replace, the relationship that exists between you and your doctor.